Ultreum Capital is a private investment firm that specializes in the innovation Biotechnology and Pharmaceutical sectors in the USA.
We execute unique investments in early stage companies that have demonstrated proof of concept and are at an inflection point of large scale growth. While our core focus is in Life Science, we have diversified our portfolio by investing in the disruptive Technology sector as well.
Ultreum is a financial and strategic investor with a strong network across USA, Europe, Middle East, and Asia. We support our portfolio companies by facilitating strategic alliances and raising of additional capital along with our network of global affiliates.
The companies within our portfolio have reputable founders and management teams along with the foremost strategic investors such as BlackRock, Johnson and Johnson, Citi Ventures, HP, Samsung, and PepsiCo.
Clinical and commercial stage Life Science companies specialised in novel therapeutics and vaccines.
Disruptive growth stage companies across Cloud, Artificial Intelligence, Cybersecurity, and Fintech.
Ultreum collaborates and syndicates with global market leaders and early stage Life Science companies to create: